Preventing fungal contamination in pharmaceuticals
While fungal contamination detection in pharmaceutical manufacturing remains a challenge, preventive practices and policies must be followed, research states.
List view / Grid view
While fungal contamination detection in pharmaceutical manufacturing remains a challenge, preventive practices and policies must be followed, research states.
The FDA is seeking closer collaboration with state authorities to ensure the quality of compounded drugs and the public’s access to them...